Examples of 'use in patients with severe' in a sentence
Meaning of "use in patients with severe"
use in patients with severe: indicating a specific treatment, medication, or procedure appropriate for individuals with serious or critical conditions. This phrase is commonly seen in medical contexts when discussing interventions for severe health issues
How to use "use in patients with severe" in a sentence
Basic
Advanced
use in patients with severe
Use in patients with severe hepatic impairment is not recommended.
Tarceva is not recommended for use in patients with severe hepatic dysfunction.
Use in patients with severe renal impairment creatinine clearance.
Jorveza is not recommended for use in patients with severe renal impairment.
Use in patients with severe renal insufficiency or severe hepatic impairment.
Tarceva is not recommended for use in patients with severe liver or kidney disease.
Use in patients with severe hepatic impairment see section 4.2.
Aerivio Spiromax is for use in patients with severe asthma only.
Xadago use in patients with severe hepatic impairment is contraindicated see section 4.3.
Airexar Spiromax is for use in patients with severe asthma only.
Therefore, use in patients with severe hepatic impairment is not recommended.
Victoza is not recommended for use in patients with severe hepatic impairment see section 5.2.
Rasagiline use in patients with severe hepatic impairment is contraindicated see section 4.3.
ONIVYDE is not recommended for use in patients with severe renal impairment CLcr < 30 ml / min.
Therefore, its use in patients with severe uncontrolled high blood pressure is now contraindicated.
Pixuvri is not recommended for use in patients with severe excretory hepatic impairment, see section 4.3.
Safinamide use in patients with severe hepatic impairment is contraindicated ( see section 4.3 ).
Olumiant is not recommended for use in patients with severe hepatic impairment ( see section 5.2 ).
Quinsair is not recommended for use in patients with severe renal impairment creatinine clearance ˂ 20 ml / min.
It is not recommended for use in patients with severe hepatic impairment ( see section 4.4 ).
Information for lorlatinib use in patients with severe ( CLcr, < 30 mL / min ) renal impairment is very limited.
You'll also be interested in:
Examples of using Severe
Show more
This place has a severe tonal problem
Severe thermal burns can occur on contact
There are mild and severe cases of frostbite
Examples of using Use
Show more
Use this machine with long trousers
Description of method of use with practical example
Do not use the instrument to heat inflammable
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
